Combating the obesity epidemic: Community pharmacists' counseling on obesity management

Annals of Pharmacotherapy

Volumn 38, Issue 11, 2004, Pages 1800-1804

  Dastani, Homa B ^a   Brown, Carolyn M ^a   O'Donnell, Dannielle C ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Primary Care Medical Liaison   (United States)

Author keywords

Obesity management; Pharmacist counseling

Indexed keywords

ANTIOBESITY AGENT; HERBACEOUS AGENT;

ADULT; DIET THERAPY; EPIDEMIC; EXERCISE; FEMALE; HUMAN; MALE; OBESITY; PATIENT COUNSELING; PHARMACIST; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; UNITED STATES; WEIGHT REDUCTION;

COMMUNITY PHARMACY SERVICES; COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; QUESTIONNAIRES; TEXAS;

EID: 7044271172     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E205     Document Type: Review

References (24)

1. Flegal KM, Carrol MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-7.
2. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998;6:97-106.
3. Small RE, Reeves R, Ferst K. Obesity: managing comorbidities of the disease. J Am Pharm Assoc 2000;40(5 suppl 1):S42-3.
4. US Department of Health and Human Services. Healthy people 2010: understanding and improving health. 2nd ed. 2 vols. Washington, DC: US Government Printing Office, 2000.
5. Lyznicki JM, Young DC, Riggs JA, Davis RM. Obesity: assessment and management in primary care. Am Fam Physician 2001;63:2185-96.
6. Murphree D. Patient attitudes toward physician treatment of obesity. J Fam Pract 1994;38:45-8.
7. Wadden TA, Berkowitz RI, Vogt RA, Steen SN, Stunkard AJ, Foster GD. Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach. Obes Res 1997;5:218-26.
8. ASHP Commission on Therapeutics. ASHP therapeutic position statement on the safe use of pharmacotherapy for obesity management in adults. Am J Health Syst Pharm 2001;58:1645-55.
9. Chandra A, Malcolm N, Fetters M. Practicing health promotion through pharmacy counseling activities. Health Promot Pract 2003;4:64-71.
10. Dickson WM, Rodowskas CA. Verbal communications of community pharmacists. Med Care 1975;13:486-98.
11. Miller MJ, Ortmeir BG. Factors influencing the delivery of pharmacy services. Am Pharm 1995;NS35:39-45.
12. Lamsam GD, Kropff MA. Community pharmacists' assessments and recommendations for treatment in four case scenarios. Ann Pharmacother 1998;32:409-16. DOI 10.1345/aph.17287
13. Christensen DM, Hanses RW. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting. J Am Pharm Assoc 1999;39:640-9.
14. Raisch DW Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings. Ann Pharmacother 1993;27:1173-9.
15. Schommer JC, Weiderholt JB. A field investigation of participant and environment effects on pharmacist-patient communication in community pharmacies. MedCare 1995;33:567-84.
16. Kotecki JE. Factors related to pharmacists' over-the-counter recommendations. J Commun Health 2002;27:291-306.
17. Krueger KP, Flekey BG, Berger BA. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative. J Am Pharm Assoc 2003;43:668-79.
18. Grenway FL, Ryan DH, Bray GA, Rood JC, Tucker EW, Smith SR. Pharmaceutical cost savings of treating obesity with weight loss medications. Obes Res 1999;7:523-31.
19. Malone M, Alger-Mayer SA. Pharmacist intervention enhances adherence to orlistat therapy. Ann Pharmacother 2003;37:1598-602. DOI 10.1345/aph.1D183
20. Centers for Disease Control and Prevention. Adverse events associated with ephedrine-containing products-Texas, December 1993-September 1995. MMWR Morb Mortal Wkly Rep 1996;45:689-92.
21. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993;341:387-91.
22. Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again: ephedrine nephrolithiasis. Am J Kidney Dis 1998;32:133-9.
23. Fugh-Berman A. Herb-drug interactions. Lancet 2000;355:134-8.
24. Brown CM, Barner JC, Shepherd MD. Issues and barriers related to the provision of pharmaceutical care in community health centers and migrant health centers. J Am Pharm Assoc 2003;43:75-7.